Thu. Jun 20th, 2024

Moroccan Dr. Najat Touati described the judicial ruling in her favor of financial compensation against the AstraZeneca vaccine as a fair ruling, which came after a marathon trial.

The researcher and university professor revealed in press statements that her case began after she received the first dose of the AstraZeneca vaccine on February 5, 2021, when she felt tingling and numbness, followed by the appearance of serious symptoms such as paralysis of the lower limbs, and inflammation that rose to the face, which led to disruption of movement of the face and eyes and inability to move. Swallowing and speech, leading to coma and loss of consciousness.

Touati said that she was treated with expensive medicine from the blood transfusion center in Rabat, which raised her concerns about the ability of ordinary citizens to afford the cost of treatment.

After five days of treatment, she began to gradually regain her movement and ability to speak, which led her to a long journey of medical rehabilitation, according to the Moroccan university’s account.

In her quest for justice, Tawati wrote to the World Health Organization, which advised her to verify the source of the vaccine, and since the dose came from a Moroccan government program to purchase vaccines, she filed a lawsuit against the Moroccan Ministry of Health.

On February 9, 2024, the Administrative Court in Rabat ruled in favor of Touati to pay financial compensation worth $25,000.

Despite the legal victory, Al-Tawati still suffers from health repercussions that prevent her from returning to her fully normal life. She works remotely with doctoral students and sometimes attends conferences, but she finds it difficult to concentrate due to the constant feeling of weakness, as she described it.

Tunisia leads the Maghreb countries in the Global Youth Development Index

Related Post